Synaptic regulation of the hypothalamic–pituitary–adrenal axis and its modulation by glucocorticoids and stress by Benjamin H. Levy & Jeffrey G. Tasker
“fncel-06-00024” — 2012/5/9 — 20:17 — page 1 — #1
CELLULAR NEUROSCIENCE
REVIEW ARTICLE
published: 11 May 2012
doi: 10.3389/fncel.2012.00024
Synaptic regulation of the hypothalamic–pituitary–adrenal
axis and its modulation by glucocorticoids and stress
Benjamin H. Levy1 and Jeffrey G.Tasker1,2*
1 Neuroscience Program, Tulane University, New Orleans, LA, USA
2 Department of Cell and Molecular Biology, Tulane University, New Orleans, LA, USA
Edited by:
Harmen J. Krugers, Universiteit van
Amsterdam, Netherlands
Reviewed by:
Yang Dan, University of California
Berkeley, USA
CoretteWierenga, Utrecht University,
Netherlands
*Correspondence:
Jeffrey G. Tasker, Department of Cell
and Molecular Biology, Tulane
University, 2000 Percival Stern Hall,
New Orleans, LA 70118-5221, USA.
e-mail: tasker@tulane.edu
Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis has been implicated in
a range of affective and stress-related disorders. The regulatory systems that control
HPA activity are subject to modulation by environmental inﬂuences, and stressful life
events or circumstances can promote subsequent HPA dysregulation. The brain is a
major regulator of the HPA axis, and stress-induced plasticity of the neural circuitry
involved in HPA regulation might constitute an etiological link between stress and the
development of HPA dysregulation. This review focuses on the synaptic regulation of
neuroendocrine corticotropin-releasing hormone (CRH) neurons of the hypothalamic par-
aventricular nucleus, which are the cells through which the brain predominantly exerts its
inﬂuence on the HPA axis. CRH neuronal activity is largely orchestrated by three neuro-
transmitters: GABA, glutamate, and norepinephrine.We discuss our current understanding
of the neural circuitry through which these neurotransmitters regulate CRH cell activity, as
well as the plastic changes in this circuitry induced by acute and chronic stress and the
resultant changes in HPA function.
Keywords: corticosteroid, glutamate, GABA, norepinephrine, neural circuits, depression, synaptic plasticity,
paraventricular nucleus
INTRODUCTION
Glucocorticoids are released in response to physical, emotional,
and/or metabolic stress, and many of the effects of glucocorti-
coids are thought to serve as adaptive responses to stressful events
or circumstances. Physiological levels of glucocorticoids are reg-
ulated by the hypothalamic–pituitary–adrenal (HPA) axis, which
is responsible for a cascade of hormone signals that begins in the
brain and ends with glucocorticoid secretion from the adrenal cor-
tex. An additional component of the HPA axis is a glucocorticoid-
mediated negative feedback mechanism, wherein glucocorticoids
act on the anterior pituitary and in the brain to suppress HPA
activity. Given the association between glucocorticoids and stress,
it is not surprising that abnormal regulation of the HPA axis is
commonly associated with a range of affective and stress-related
disorders. Research into these phenomena has dealt mostly with
hypersecretion of glucocorticoid in patients with depressive ill-
ness (Gillespie and Nemeroff, 2005), although there has also been
interest in the hyposecretion of glucocorticoids found in some
cases of post-traumatic stress disorder (Yehuda, 2006) and depres-
sion (Morphy et al., 1985; Penninx et al., 2007; Ahrens et al., 2008).
Dysregulation of the HPA axis has also been associated with panic
disorder (Abelson et al., 2007), chronic fatigue syndrome (Van
Houdenhove et al., 2009), obsessive-compulsive disorder (Gustafs-
son et al., 2008), ﬁbromyalgia (Tanriverdi et al., 2007), generalized
anxiety disorder (Lenze et al., 2011), and bipolar disorder (Daban
et al., 2005). Importantly, stressful life events have been impli-
cated in the onset of each of these disorders (Kendler et al., 1995;
Hatcher and House, 2003; Gupta and Silman, 2004; Brawman-
Mintzer et al., 2005; Garno et al., 2005; Goodwin et al., 2005;
Sarkhel et al., 2011), and dysregulation of the HPA axis may be an
etiological link between stress and the subsequent development
of pathology.
The physiological origins of stress-induced variation in HPA
regulation have remained largely unknown, although rodentmod-
els have shed some light on thematter, largely by providing insight
into the ways that the brain regulates HPA activity. In fact, the
neural circuitry that regulates the HPA axis has been found to be
highly plastic, and that plasticity is induced by both stress and
changes in glucocorticoid levels. It is possible that exposure to
stress and/or the resultant ﬂuctuations in circulating glucocorti-
coids results in pathology by evoking long-lasting alterations in
the circuitry that regulates the HPA axis. Here, we will review
what is known about the synaptic regulation of the HPA axis and
the plasticity of the circuitry regulating the HPA axis induced
under stress conditions. We will focus on the neuroendocrine
corticotropin-releasing hormone (CRH) cells, which are located
in the paraventricular nucleus (PVN) of the hypothalamus and
are situated at the apex of the HPA axis. The CRH cells are of
particular interest because it is principally through the regulation
of CRH release into the portal circulation that the brain exerts
its inﬂuence on the HPA axis. As with all neurons, CRH cells
are stimulated by depolarization of their cell membrane, which
stimulates action potentials and triggers the release of peptide
from their axon terminals. However, unlike with classical neurons,
these terminals do not form synapses with postsynaptic neurons;
but rather, they are incorporated into a region at the base of the
brain, themedian eminence, where released neuropeptide accesses
the pituitary portal circulation via fenestrated portal arterioles.
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In addition to CRH, the CRH cells can synthesize and release
vasopressin (VP). CRH and VP in the portal circulation bind to
CRH andVP receptors on a subset of cells, the corticotropes, of the
anterior pituitary to stimulate the secretion of adrenocorticotropic
hormone (ACTH) into the systemic circulation. The ACTH then
stimulates the synthesis and systemic secretion of glucocorticoids
from the adrenal cortex. Hypothalamic CRH neuronal activity is
largely orchestrated by three neurotransmitters: GABA, glutamate,
and norepinephrine. In this review we discuss our current under-
standing of how these neurotransmitter systems regulate CRH
neuron activity (and consequently HPA activity), and the mod-
ulation of these neurotransmitter systems by glucocorticoids and
stress. One aim of this review is to provide a framework to help
guide future investigations of the synaptic regulation of CRH cells
that have the potential to advance our understanding of the neu-
rological bases for HPA dysfunction. It is also an aim of this paper
to inform those who study stress-induced abnormalities in HPA
activity, but who may not be familiar with studies of synaptic
transmission, in the hope of making these studies more accessi-
ble for the purpose of enhancing communication and promoting
interdisciplinary investigations.
METHODS OF IDENTIFYING CRH CELLS
Inasmuch as CRH cells play such a central role here, before dis-
cussing the synaptic regulation of the CRHneurons, wewill brieﬂy
address the challenges in identifying the CRH cells in the course
of physiological experiments. The PVN can be divided into three
major cell types: the magnocellular neuroendocrine cells, which
project their axons into the posterior lobe of the pituitary, the
parvocellular neuroendocrine cells, which send their axons to the
median eminence, and the parvocellular preautonomic neurons,
which project to the brain stem and spinal cord. The CRH neu-
rons fall into the parvocellular neuroendocrine cell type. The
three cell types can be distinguished with reasonable reliability
on the basis of their respective somatic sizes and shapes, den-
dritic morphologies, and positions in the PVN. Magnocellular
neuroendocrine cells tend to have larger, more rounded somata
and fewer dendritic branches, often bipolar in morphology, com-
pared to the parvocellular neuroendocrine cells, which tend to
be smaller, fusiform, and with multipolar dendritic arbors. The
magnocellular neuroendocrine cells are concentrated in the lat-
eral portion of the PVN, while the parvocellular neuroendocrine
cells are located mainly in the medial region of the PVN. The
dorsal-most and ventral-most regions of the PVN tend to be
occupied by the parvocellular preautonomic neurons, which are
intermediate in somatic size between the parvocellular neuroen-
docrine cells and themagnocellular neuroendocrine cells, andhave
multipolar dendritic arbors. While this morphological and topo-
graphical organization of the PVN can be used to identify enriched
populations of the different subtypes of PVN neurons, there is
fairly extensive overlap of the anatomical characteristics of the cell
types within the PVN (Simmons and Swanson, 2009), such that
it does not provide for a strict distillation of the three neuron
subpopulations.
Distinct electrical properties have also been characterized in the
three PVN cell types and have been used to assign electrical ﬁnger-
prints for the reliable identiﬁcation of individual cells in in vitro
electrophysiological studies (Figure 1). Magnocellular neuroen-
docrine cells generate a robust A-type voltage-dependent K+
current, which causes a prominent transient outward rectiﬁcation
that delays action potential generation (Tasker and Dudek, 1991).
Most parvocellular preautonomic neurons generate a T-type Ca2+
current, which causes a small low-threshold spike and clustering
of Na+-dependent action potentials (Stern, 2001; Luther et al.,
2002). Parvocellular neuroendocrine cells can be distinguished
from both magnocellular neuroendocrine cells and parvocellular
preautonomic cells by the absence of both the transient outward
rectiﬁcation and the low-threshold Ca2+ spike (Luther and Tasker,
2000; Luther et al., 2002; Figure 1).
While useful for narrowing down the ﬁeld of the three cell
subtypes, these anatomical and electrophysiological approaches
do not allow investigators to speciﬁcally distinguish CRH neu-
rons from the other PVN parvocellular neuroendocrine cells,
such as thyrotropin releasing hormone and somatostatin cells.
Electron and confocal microscopy immunohistochemical stud-
ies using selective antibodies for CRH and for neurotransmitters
or vesicular neurotransmitter transporters have been useful for
characterizing the anatomical innervation of CRH neurons and
its plasticity in response to stress and adrenalectomy (Flak et al.,
2009). Because basal CRH peptide expression is not robust,
attempts to identify CRH neurons during electrophysiological
recordings with a combination of intracellular dye injection and
post hoc immunostaining for CRH have been largely unsuccess-
ful. One method that has been useful for speciﬁcally targeting
CRH cells for synaptic analysis is intracellular recording com-
bined with single-cell, reverse transcription–PCR analysis (Di
et al., 2003). This technique allows the correlation of molecular
expression proﬁles, including CRH mRNA expression, with elec-
trophysiological properties. Transgenic mice that express green
ﬂuorescent protein under the transcriptional control of the CRH
promoter have recently become available (Alon et al., 2009) and
offer the greatest promise for contributing signiﬁcantly to the
study of the synaptic regulation of identiﬁed CRH neurons
and the synaptic plasticity of CRH neurons under conditions of
stress.
GABA INPUTS
Origins of GABA inputs to the PVN have been identiﬁed through
the use of tract tracing in conjunction with immunohistochemical
staining, as well as through in vitro electrophysiological analy-
ses. A retrograde tracing-immunohistochemistry study revealed
four discrete origins of signiﬁcant GABAergic innervation of the
PVN, which are: the area surrounding the supraoptic nucleus, the
anterior perifornical region, the anterior hypothalamic area, and
the anterior one-third of the PVN itself (Roland and Sawchenko,
1993). There is also evidence from tract tracing studies for a
prominent GABAergic projection from the bed nucleus of the
stria terminalis (BNST) to the PVN that relays inhibitory sig-
naling to CRH cells from the prefrontal cortex (Radley et al.,
2009) and the hippocampus (Radley and Sawchenko, 2011). Stud-
ies employing in vivo ibotenic acid lesions of subnuclei of the
BNST have implicated speciﬁcally the posterior medial region
of the bed nucleus as an inhibitory relay from limbic struc-
tures to the PVN (Choi et al., 2007, 2008). An in vitro brain
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FIGURE 1 | Distinct electrophysiological fingerprints of PVN
magnocellular and parvocellular neurons. (A) Magnocellular
neuroendocrine cells recorded in current-clamp mode generate an A-type K+
current-mediated transient outward rectiﬁcation (arrow) that is generated by
depolarization from a hyperpolarized holding membrane potential and delays
the onset of spiking. Lower traces: current injection protocol. (B) Parvocellular
neuroendocrine cells fail to generate a transient outward rectiﬁcation and
delay to spiking (arrow) in response to a similar current injection protocol.
(C) Parvocellular preautonomic cells do not display a transient outward
rectiﬁcation, but generate a low-threshold spike (arrow), mediated by aT-type
Ca2+ current, and clustered action potentials in response to a similar current
injection protocol. Modiﬁed from Luther andTasker (2000).
slice electrophysiological study identiﬁed robust local GABAer-
gic innervation of both parvocellular and magnocellular neurons
of the PVN that originates in the perinuclear area surrounding the
PVN (Boudaba et al., 1996). The perinuclear PVN area has also
been postulated to serve as an inhibitory relay into the PVN from
upstream limbic structures, such as the hippocampus and septum
(Ziegler and Herman, 2002).
The inhibitory effect of GABA on CRH cells is mediated pri-
marily by GABAA receptors. In situ hybridization assays detected
the expression of the GABAA receptor α2, β1, and β3 subunits in
nearly all the CRH cells of the PVN, and expression of α1 and
β2 in about half of the CRH cells (Cullinan, 2000). Interestingly,
microinjection of a GABAA receptor antagonist into the PVN is
sufﬁcient to activate CRH cells and elicit a surge in glucocorticoid
secretion (Cole and Sawchenko, 2002), revealing a tonic inhibitory
GABAergic input in the PVN that constrains CRH neuronal activ-
ity under basal conditions. The tonic inhibition of CRH neurons
is preserved in organotypic hypothalamic slice cultures contain-
ing the PVN (Bali and Kovacs, 2003), which suggests that local
GABA neuronal circuitry (i.e., GABA circuitry retained through
the slicing procedure) plays a central role in this mechanism. The
source of local GABAergic innervation of the PVN CRH neurons
is predominantly extranuclear (Figure 2), including a robust input
from the peri-PVN region (Boudaba et al., 1996).
STRESS PLASTICITY OF GABA INPUTS
Acute stress plasticity of GABA inputs
The GABAergic synaptic innervation of PVN neurons undergoes
signiﬁcant plastic changes in response to acute stress, which alters
the excitability of the parvocellular neurons and activation of the
HPA axis. A 30–60 min acute restraint stress is enough to cause a
signiﬁcant shift in the Cl− gradient across the PVN parvocellular
neuron membrane via downregulation of the membrane K+–Cl−
co-transporter KCC2. This shift in the Cl− gradient causes a post-
synaptic attenuation of the inhibitory GABAergic inputs to these
cells and leads to the disinhibition of the HPA axis (Hewitt et al.,
2009). It is not known whether glucocorticoids modulate KCC2
FIGURE 2 | Model of noradrenergic regulation of PVN CRH neuron
activity. Noradrenergic inputs (NE) originate in the brainstem and regulate
CRH neuronal activity by modulating glutamate and GABA release.
Norepinephrine both suppresses and enhances GABAergic inhibition of
CRH neuron activity, suppressing GABA release via α2-adrenoceptor
activation at presynaptic terminals and promoting GABA release by
activating α1-adrenoceptors on upstream GABAergic somata/dendrites.
Noradrenergic facilitation of glutamate release onto CRH neurons is
spike-dependent and is mediated by α1-adrenoceptor activation.
Preliminary evidence suggests that the facilitatory effect on glutamate
release may be mediated by the release of a retrograde messenger that
stimulates upstream local glutamatergic circuits (dashed arrow). 3V, thrid
ventricle; OT, optic tract.
expression, although KCC2 expression has been found to be sub-
ject to steroidal modulation by sex hormones in substantia nigra
neurons wherein, at postnatal day 15, GABAA receptors are hyper-
polarizing in females and depolarizing in males (Galanopoulou
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and Moshe, 2003). Interestingly, a similar phenomenon has been
discovered in the magnocellular neurons of the PVN, in which
the GABAA reversal potential shifts positive and the GABA signals
are transformed into excitatory signals in oxytocinergic magno-
cellular neurons following dehydration, a chronic physiological
stress (Kim et al., 2011); GABA was shown to be excitatory in
VP cells, but not in oxytocin cells, under normal conditions
(Haam et al., 2012).
Acute stress also appears to induce a long-term presynap-
tic plasticity in the GABAergic inhibitory innervation of PVN
parvocellular neurons via a transient elevation in circulating glu-
cocorticoids. Thus, a 30-min acute restraint stress was found to
cause a persistent reduction in inhibitory synaptic inputs to puta-
tive parvocellular neurons in recordings performed in brain slices
in vitro up to 5 h later, and this effect was mimicked by a pre-
vious in vivo subcutaneous injection of glucocorticoid (Verkuyl
et al., 2005). These changes in inhibitory inputs were not spike-
dependent, suggestive of plasticity in theGABA release probability,
which was corroborated with paired-pulse analysis. An acute
20-min glucocorticoid application directly to brain slices had no
rapid effect (<20 min) on GABAergic synaptic currents (Di et al.,
2003), but resulted in a similar presynaptic suppression of GABA
inputs to PVN parvocellular neurons 1–5 h later (Verkuyl et al.,
2005), suggesting that these presynaptic glucocorticoid actions are
transcriptional and occur directly in the hypothalamus.
GABAergic synaptic plasticity may also play a role in the HPA
response to hypoglycemic stress via signaling through neuropep-
tide Y (NPY). There is a high density of NPY projections that
terminate in the medial parvocellular PVN (Cowley et al., 1999),
many of which originate in the arcuate nucleus, a hypothalamic
region that provides access to the brain of circulating nutritional
signals (Wang et al., 2004). Both insulin-induced hypoglycemia
(Tuchelt et al., 2000) and intracerebroventricular injection of NPY
(Dimitrov et al., 2007) activate the HPA axis and cause an increase
in the circulating glucocorticoid level. In vitro electrophysiological
studies reported that NPY caused a decrease in the probabil-
ity of GABA release onto putative parvocellular PVN neurons
via actions at multiple presynaptic NPY receptors (Cowley et al.,
1999). The role of HPA axis activation in response to hypo-
glycemia may be related to the fact that glucocorticoids increase
glucose bioavailability by shifting metabolic processes towards
catabolism.
Chronic stress plasticity of GABA inputs
Chronic stress and sustained changes in systemic glucocorticoid
levels also lead to long-term shifts in the GABAergic synaptic
innervation of the PVN parvocellular neurons. Adrenalectomy,
for example, which eliminates the main endogenous source of
circulating glucocorticoids, leads to an increase in the number
of GABAergic synapses and in the density of GABA receptors
on CRH neurons, suggesting that the loss of circulating gluco-
corticoids induces a proliferation of afferent GABAergic synaptic
inputs to CRH neurons. Thus, quantitative electron microscopic
analysis of immunocytochemically labeled GABAergic synaptic
proﬁles revealed a ∼55% increase in the number of GABAer-
gic synapses on CRH cells in the PVN of adrenalectomized rats
(Miklos and Kovacs, 2002). An in vitro electrophysiological study
provided a physiological corroboration with the ﬁnding that puta-
tive parvocellular PVN neurons undergo a signiﬁcant increase
in inhibitory synaptic inputs in brain slices from adrenalec-
tomized rats, and paired-pulse analysis suggested that this effect of
adrenalectomywas due to an increase in the number of GABAergic
synapses (Verkuyl and Joels, 2003). Glucocorticoid replacement
in this study conﬁrmed that the effect of adrenalectomy was
due to the loss of endogenous glucocorticoids. Finally, binding
of radiolabeled muscimol, a selective GABAA receptor agonist,
was found to increase in the hypothalamus following adrenalec-
tomy, suggesting an increase in postsynaptic expression or mem-
brane localization of GABAA receptors following adrenalectomy
(Majewska et al., 1985).
Whereas the loss of endogenous glucocorticoids by adrenalec-
tomy was shown to increase the number of GABAergic synapses
on CRH cells, chronic stress and chronically high glucocorticoid
levels were reported to suppress GABAergic inhibitory synaptic
inputs to PVN parvocellular neurons. In vitro electrophysiologi-
cal recordings from putative parvocellular neurons in PVN brain
slices taken after 3 weeks of a chronic variable stress treatment,
which leads to sustained elevated glucocorticoids (Herman et al.,
1995), revealed a decrease inGABAergic inhibitory synaptic inputs
to parvocellular neurons without an accompanying reduction in
the probability of release of GABA, suggesting a reduced num-
ber of GABAergic synapses (Joels et al., 2004; Verkuyl et al., 2004).
A confocal immunoﬂuorescence study, however, failed to detect
a reduction in the density of GABAergic synaptic boutons on
CRH neurons in the medial parvocellular PVN, although these
measurements were taken following a shorter exposure (1 week)
to the chronic variable stress treatment (Flak et al., 2009). The
acute glucocorticoid-induced reduction in GABA release proba-
bility and the chronic glucocorticoid-induced decrease in GABA
synapses, in conjunctionwith the adrenalectomy-induced increase
in GABAergic synapses, suggest that there is an inverse causal
relationship between glucocorticoid levels and the efﬁcacy of
GABAergic synaptic inhibition of CRH cell activity. Both acute
and chronic stress, therefore, appear to downregulate GABAergic
synaptic transmission in PVN parvocellular neurons, albeit in dif-
ferent ways. The progression from acute stress to chronic stress
plasticity in the functional inhibitory synaptic regulation of par-
vocellular PVN neurons appears generally to involve a transition
from amodulation of GABAergic synaptic strength to a structural
modiﬁcation of afferent GABA inputs.
While, to our knowledge, an analysis of the changes in the den-
sity of GABAA receptors in the PVN following chronic variable
stress is still lacking, molecular studies on chronic stress-induced
changes in GABAA receptor expression in the PVN have been
performed, and have produced somewhat contradictory ﬁndings.
An in situ hybridization study reported a decrease in the expres-
sion of the GABAA receptor β1 and β2 subunits (Cullinan and
Wolfe, 2000). Another study using a single-cell RNA ampliﬁcation
approach reported no change in the β receptor subunit expres-
sion, but an elevated expression of the α5 subunit and decreased
expression of the δ subunit in putative parvocellular PVN neurons
following chronic variable stress (Verkuyl et al., 2004). However,
the absence of a change in β-subunit expression in the latter study
may have been a consequence of the small sample size, as the
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investigators themselves concede. While the regulation of the α5
and δ GABAA receptor subunits may suggest a stress-induced
change in extrasynaptic GABAA receptor signaling, the decrease
in β1 and β2 subunits expression should lead to the downregu-
lation of functional synaptic GABAA receptors and/or a change
in synaptic GABAA receptor efﬁcacy. Corresponding changes in
postsynaptic GABAA receptor sensitivity have not been reported
to date.
GLUTAMATE INPUTS
Double immunohistochemical labeling for the vesicular glutamate
transporter VGlut2 and for CRH has shown that PVN CRH neu-
rons are densely innervated by glutamatergic ﬁbers (Wittmann
et al., 2005). Electrophysiological experiments have determined
that functional local circuit glutamatergic innervation of puta-
tive parvocellular neurons originates in areas adjacent to the PVN,
largely overlapping sources of peri-PVN GABAergic input, but at
a much lower density (Boudaba et al., 1997; Tasker et al., 1998).
There is also evidence that glutamatergic input to PVN neurons
originates within the PVN itself (Figure 2). First, CRH-, oxytocin-,
and VP-expressing neurons in the PVN have all been shown
to co-express VGlut2 mRNA (Hrabovszky and Liposits, 2008).
In vitro brain slice electrophysiological recordings from putative
magnocellular neurons of the PVN revealed a norepinephrine-
evoked stimulation of local glutamate circuits within the PVN
that was spike-dependent, suggesting the presence of glutamater-
gic neurons in the PVN thatmediate intra-PVN signaling (Daftary
et al., 1998). Furthermore, intra-PVN glutamatergic circuits were
also revealed in an autoradiographic study in which sources of
glutamatergic input to the PVN were identiﬁed using the radi-
olabeled retrograde marker [3H]D-aspartate, which selectively
labels glutamate neurons (Csaki et al., 2000). In addition to the
peri-PVN and intra-PVN sources of glutamatergic inputs to the
PVN, signiﬁcant glutamatergic afferents to the PVN have also
been identiﬁed emanating from the ventromedial hypothalamic
nucleus, the posterior hypothalamic nucleus, the dorsomedial
hypothalamic nucleus, the anterior hypothalamic nucleus, the lat-
eral hypothalamic nucleus, the paraventricular thalamic nucleus,
and the medial nucleus of the amygdala (Csaki et al., 2000;
Ulrich-Lai et al., 2011).
Microinjection of glutamate into the PVNcaused a depletion of
CRH in themedian eminence and activation of theHPAaxis (Feld-
man and Weidenfeld, 1997), and microinjection of an ionotropic
glutamate receptor antagonist into the PVN attenuated the HPA
hormonal response to acute restraint stress (Ziegler and Herman,
2000). The inconsistent activation of CRH neurons and the HPA
axis by direct PVN glutamate microinjection reported in another
study (Cole and Sawchenko, 2002) is likely due to the desensiti-
zation of the ionotropic glutamate receptors on the PVN neurons
and/or stimulation of opposing inhibitory inputs via the activation
of local circuit neurons upstream from the PVN neurons. Double-
label immunohistochemical assays, for example, have shown that
glutamate microinjection into the PVN increases Fos induction
in peri-PVN GABAergic neurons, which may project to the CRH
cells and oppose the direct excitatory actions of glutamate.
Molecular studies have reported the expression of multiple
subtypes of ionotropic and metabotropic glutamate receptors
(mGluRs) in the PVN. One in situ hybridization study that used
riboprobes reported that mRNAs for the NMDA receptor sub-
units GluN1, GluN2A, and GluN2B are abundantly expressed
in the medial parvocellular PVN, whereas there is signiﬁcantly
less expression of the GluN2C and GluN2D subunits (Herman
et al., 2000). This study also reported substantial expression in the
medial parvocellular PVN of the kainate receptor subunits GluK2
and GluK5 and of the AMPA receptor GluA1 subunit. Another
in situ hybridization study that used oligonucleotide probes to test
for the colocalization of ionotropic glutamate receptor subunits
with CRH found mRNAs for the AMPA receptor subunits GluA1
and GluA2 to be present in 46 and 21% of CRH cells, respectively,
andmRNA for the kainate receptor subunit GluK2 to be present in
31% of CRH cells (Aubry et al., 1996). This study also found that
70% of CRH cells expressed the NMDA receptor subunit GluN1
mRNA, but no colocalization with either GluN2A or GluN2B sub-
units was detected. The difference in GluN2 expression between
these two studiesmay be due to the higher sensitivity of riboprobes
relative to oligonucleotide probes. Thus, it appears that kainate,
AMPA, and NMDA receptors all play a role in mediating gluta-
matergic input to CRH cells, with the AMPA receptor subunit
GluA1 predominating over the GluA2 subunit, and the NMDA
receptor subunits GluN2A and GluN2B predominating over the
GluN2C and GluN2D subunits.
In addition to ionotropic glutamate receptors, mGluRs play
a role in the regulation of CRH cell activity (Durand et al.,
2008). Double-label immunocytochemistry revealed the pres-
ence of mGluR1a in a signiﬁcant number of CRH cells (Kocsis
et al., 1998). Intracerebroventricular injections of selective group I
and group III mGluR agonists were found to elicit an increase
in circulating glucocorticoids (Lang and Ajmal, 1995; Johnson
et al., 2001). Unexpectedly, intracerebroventricular injections of
antagonists of the group I mGluRs were also found to trigger
the activation of the HPA axis (Bradbury et al., 2003). Based
on previous ﬁndings of a pre- and postsynaptic modulation of
magnocellular neuroendocrine cells by group I and III mGluRs
(Schrader and Tasker, 1997; Tasker et al., 1998), a similar model
for the regulation of CRH cell activity by group I and group III
mGluRs was proposed (Johnson et al., 2001). According to this
model, group III mGluRs disinhibit CRH cell activity by suppress-
ing the release of GABA onto CRH cells, and group I mGluRs
inhibit CRH cells through stimulation of afferent GABAergic neu-
rons, while postsynaptic group I mGluRs stimulate CRH cells
directly.
STRESS PLASTICITY OF GLUTAMATE INPUTS
Acute stress plasticity of glutamate inputs
Glutamatergic synaptic inputs to CRH cells are suppressed by
rapid glucocorticoid actions that appear to be involved in the
glucocorticoid-mediated fast negative feedback of the HPA axis.
Thus, corticosterone and dexamethasone cause a rapid (within
3–5 min) decrease in the frequency of miniature excitatory post-
synaptic currents (mEPSCs) in each of the major neuroendocrine
cell types of the PVN, including inCRHcells, recorded in hypotha-
lamic slices (Di et al., 2003). This rapid glucocorticoid effect is
mediated by a non-genomic mechanism via the activation of a
membrane-associated receptor. Importantly, this glucocorticoid
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effect was blocked by antagonists and mimicked and occluded by
agonists of the cannabinoid type 1 receptor (CB1R), suggesting the
involvement of the endocannabinoid system. We recently corrob-
orated this with the ﬁnding that the rapid glucocorticoid effect is
absent in CB1R knockout mice (Nahar et al., submitted). This was
supported by the ﬁnding that glucocorticoid rapidly (<10 min)
triggers the synthesis of the major endocannabinoids anandamide
(AEA) and 2-arachidonoylglycerol (2-AG) in slices of the PVN
and immediate surround (Malcher-Lopes et al., 2006). Endo-
cannabinoids signal in a retrograde fashion (i.e., frompostsynaptic
membrane to presynaptic membrane) and cause the inhibition of
presynaptic neurotransmitter release (Freund et al., 2003). Consis-
tent with the endocannabinoid acting as a retrograde messenger
to inhibit glutamate release at glutamate synapses, the glucocor-
ticoid effect was prevented by blockade of G protein and protein
kinase activity and Ca2+ signaling speciﬁcally in the postsynaptic
cell (Malcher-Lopes et al., 2006; Harris and Tasker, 2011).
Interestingly, the glucocorticoid-induced rapid suppression of
glutamate release in the PVN in vitro is not reversible in brain slice
electrophysiological studies for over an hour after dexamethasone
administration (Di et al., 2003), which indicates that glucocor-
ticoids trigger a form of endocannabinoid-mediated long-term
depression of synaptic excitation; long-term depression is recog-
nized as a widespread form of synaptic plasticity in the brain that
reduces the efﬁcacy of synaptic interactions (Heifets and Castillo,
2009). The physiological signiﬁcance of the extended duration
of the glucocorticoid-induced suppression of excitatory inputs to
CRH cells remains unknown; however, we have preliminary evi-
dence for the desensitization to the rapid glucocorticoid-induced
suppression of glutamate release in brain slices from animals that
had been subjected to an acute 30-min restraint stress prior to sac-
riﬁce (Jiang and Tasker, unpublished observation). This effect is
likely due to the long-term depression of glutamatergic synap-
tic inputs by a tonic activation of presynaptic CB1 receptors
via glucocorticoid-induced retrograde endocannabinoid release,
since a CB1 receptor-mediated inhibitory tone was observed in
glutamate inputs to parvocellular neurons from acutely stressed
rats, but not from unstressed rats. A downregulation of rapid
glucocorticoid-induced endocannabinoid suppression of synaptic
excitation was also reported in putative parvocellular neuroen-
docrine cells of juvenile rats subjected to a repeated immobi-
lization stress, although the mechanism proposed was a chronic
stress-induced desensitization of the cannabinoid signaling system
(Wamsteeker et al., 2010), rather than the increased endocannabi-
noid inhibitory tone that we ﬁnd after single exposure to an acute
stress or stress level of glucocorticoid. It remains to be deter-
mined how long the glucocorticoid-induced long-term depression
of synaptic excitation lasts, but it may be in place to provide the
time necessary for the peptidergic stores in the somata and axon
terminals to replenish after a rapid and robust secretion of CRH
and VP into the portal circulation. Also, for those mechanisms
that are sensitive to rates-of-change in glucocorticoid concen-
tration (Jacobson and Sapolsky, 1993), long-term depression of
the synaptic excitation of CRH neurons may reduce CRH release
to allow for clearance of circulating glucocorticoids in order to
ensure the sensitivity of glucocorticoid targets to the secretion of
a subsequent bolus.
N-methyl-D-aspartate receptor expression in the medial par-
vocellular PVN has also been reported to be modulated by a
single exposure to a stress stimulus. An in situ hybridization study
found that acute immobilization stress caused a ∼35% increase
in the expression of mRNA for the GluN1 subunit of the NMDA
receptor in several brain regions, including in the medial par-
vocellular PVN (Bartanusz et al., 1995). The increased GluN1
expression suggests the possibility that acute stress may cause an
overall increase in NMDA receptor function in the medial par-
vocellular PVN, since functional NMDA receptors are comprised
of a requisite GluN1 subunit (Cull-Candy et al., 2001). However,
a brain slice electrophysiological study demonstrated depressed
NMDA receptor function in individual PVN parvocellular neu-
rons following a 30-min acute immobilization stress (Kuzmiski
et al., 2010). Paradoxically, the depression of NMDA receptor cur-
rents in the parvocellular neurons following acute stress placed
the glutamate synapses in a permissive state that allowed them to
undergo activity-dependent short-term potentiation in response
to high frequency stimulation. Thus, the NMDA receptor mRNA
expression and the functionality of the receptor do not appear to
be regulated in parallel by stress, which suggests that there may be
changes in the receptor protein expression or trafﬁcking that may
account for this discrepancy.
Chronic stress plasticity of glutamate inputs
In addition to inducing an apparent functional downregulation
in the inhibitory synaptic inputs to PVN parvocellular neuroen-
docrine cells (Verkuyl et al., 2004), the chronic variable stress
model of stress plasticity also gives rise to signiﬁcant changes in the
excitatory synaptic innervation of PVN parvocellular neurons. A
double-labeling immunohistochemical study found that chronic
variable stress signiﬁcantly increased the density of synaptophysin-
expressing synaptic boutons and VGlut2-expressing glutamater-
gic ﬁbers in the medial parvocellular PVN, and increased the
number of glutamatergic boutons directly contacting CRH-
immunoreactive somata and dendrites (Flak et al., 2009). This
suggests that chronic stress causes an increase in the glutamatergic
synaptic innervation of the CRH neurons, which, along with the
reduced GABAergic innervation of medial parvocellular neurons
(Verkuyl et al., 2004), should lead to an increase in the excitability
of these neurons following chronic stress exposure. Preliminary
electrophysiological ﬁndings from our laboratory suggest that the
increased density of immunolabeled glutamate synapses on the
CRH neurons gives rise to an increase in the functional excitatory
synaptic inputs to these cells (Franco et al., 2007).
Glutamate receptor expression in the PVN has also been
reported to be modiﬁed by chronic stress exposure. An in situ
hybridization study found that 2 weeks of chronic variable stress
caused a decrease in the mRNA expression of the NMDA recep-
tor subunit GluN2B in the medial parvocellular PVN, but found
no changes in GluN1 or GluN2A subunit expression (Ziegler
et al., 2005). This effect differed from the glutamate receptor plas-
ticity induced by acute immobilization stress, which caused an
increase in the expression of GluN1 reported in the aforemen-
tioned study (Bartanusz et al., 1995). The fact that the decrease in
GluN2B induction caused by chronic stress was not accompanied
by a change in GluN1 expression suggests that the downregulated
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GluN2B does not reﬂect a decrease in the number of functional
NMDA receptors, since the GluN1 subunit is an essential com-
ponent of functional NMDA receptors (Cull-Candy et al., 2001).
The decrease in NMDA receptor mRNA expression with chronic
stress is surprising given the observation of an increase in the den-
sity of glutamate synapses with the same chronic stress paradigm
(Flak et al., 2009). This suggests either that NMDA receptor
mRNA and protein expression are differentially modulated, or
that there is less of a contribution of NMDA receptors relative to
AMPA receptors at glutamate synapses on CRH neurons follow-
ing chronic variable stress. Follow-up electrophysiological studies
will be necessary to distinguish between these possibilities. Inter-
estingly, the stress-induced downregulation of GluN2B mRNA is
apparently not mediated by glucocorticoids, as neither adrenalec-
tomy nor high-dose glucocorticoid administration produced any
change in GluN2B mRNA expression in the medial parvocellular
PVN (Ziegler et al., 2005). Thus, this plasticity of NMDA recep-
tor expression following chronic variable stress may result from
repeated activation of glutamatergic receptors with the chronic
activation of stress circuits.
Interestingly, glutamatergic synaptic plasticity resulting from
the neonatal environment might be involved in lifelong changes
in HPA responsivity. Pups that are handled daily during the ﬁrst
10 days of life have been found to exhibit a suppressed HPA
response to a novel stressor as adults (Liu et al., 1997). It is pos-
sible that this effect of handling is mediated by an increase in
maternal attention, as handled pups receive more frequent bouts
of maternal care in the form of licking, grooming, and arched-
back nursing. One study using an early-life handling paradigm
found that handled pups have lowerVGlut2 protein content in the
PVN, fewer VGlut2-immunoreactive synaptic boutons contacting
CRH cells, and fewer asymmetrical, putative excitatory, synapses
on CRH cells (Korosi et al., 2010). Electrophysiological record-
ings in putative parvocellular PVN neurons from these animals
found that the frequency of miniature EPSCs also was decreased,
suggesting a reduced excitatory synaptic input to the CRH cells.
The reduced glutamatergic input in this study was found exclu-
sively in the pups and not following maturation to adulthood,
but the handled animals exhibited life-long reductions in PVN
CRH expression, which suggests that reductions in glutamater-
gic input early in life may be involved in a cascade of events that
leads to a life-long reduction in CRH expression and HPA stress
responsivity.
NOREPINEPHRINE INPUTS
Noradrenergic input to the medial parvocellular PVN originates
in the brainstem, particularly in the nucleus of the solitary tract
(NTS; Herman et al., 2003). Norepinephrine has long been known
to play a prominent role in the regulation of the HPA axis and
has been shown to be generally excitatory with regard to modu-
lation of CRH neuron activity (Plotsky et al., 1987). Accordingly,
microinjection of norepinephrine directly into the PVN increases
CRH mRNA expression and elevates circulating ACTH in a dose-
dependent manner (Itoi et al., 1994). There has been debate,
however, regarding the role of the brainstem in driving HPA
responses to stress. It has been proposed that the brainstem
drives HPA responses to systemic stress, whereas HPA responses to
psychological stress are driven by regions in the forebrain (Li et al.,
1996). In support of this division, the glucocorticoid response to
immune stress caused by intraperitoneal injection of interleukin-
1α was found to be attenuated by depletion of noradrenergic
inputs to the PVN, whereas no such effect of the depleted inputs
was observed on the HPA responses to restraint stress (Chuluyan
et al., 1992) or footshock stress (Li et al., 1996). However, later ﬁnd-
ings would suggest that ascending noradrenergic signaling plays a
role in driving HPA responses to both systemic and psycholog-
ical stress (Pacak et al., 1998; Dayas et al., 2001). More recently,
Herman et al. (2003) presented an alternative model regarding the
role of the brainstem in HPA responses to stress. According to
this model, the extent to which the NTS promotes HPA activity
results from an interaction between ascending sensory inputs to
the NTS and descending inputs to the NTS from the forebrain.
It was proposed that the ascending input to the NTS transmits
information regarding the current homeostatic state, whereas
descending input to the NTS transmits information regarding an
anticipated homeostatic state. As a result of this convergence of
signaling in the NTS, the HPA response to an anticipated home-
ostatic state would depend on the current homeostatic state, so
that inhibitory signaling from the forebrain can be overridden by
current somatic, visceral, or humoral disturbances; alternatively,
excitatory signaling from the periphery to themedial parvocellular
PVN could be modulated by descending contextual information
(Herman et al., 2003).
Electrophysiological analyses have revealed mixed effects of
norepinephrine on putative parvocellular neuroendocrine cells
of the PVN; some cells are excited and other cells are inhibited
by norepinephrine (Yang et al., 2007). The excitatory actions of
norepinephrine on CRH cells appear largely to be mediated by
modulation of glutamatergic synaptic inputs. Thus, the surge
in circulating ACTH and glucocorticoids resulting from electri-
cal stimulation of the ventral noradrenergic bundle was found
to be inhibited by intra-PVN microinjection of ionotropic gluta-
mate receptor antagonists in a dose-dependent manner (Feldman
and Weidenfeld, 2004). An electrophysiological study found that
about 36% of putative parvocellular neurons responded to nore-
pinephrine with an increase in glutamatergic input, while another
14% responded with a hyperpolarization (Daftary et al., 2000).
Post-recording biocytin labeling revealed that the cells that had
exhibited a norepinephrine-induced hyperpolarization tended to
be located close to the third ventricle in a region known to con-
tain dopamine and/or somatostatin parvocellular neurons, so it
is possible that none of the hyperpolarized neurons were CRH
cells. The norepinephrine-induced increase in glutamatergic activ-
ity was mediated by α1-adrenoceptors and was spike-dependent.
Perhaps the most surprising result from our electrophysiologi-
cal studies is the absence of putative parvocellular neurons that
are excited by norepinephrine directly (Daftary et al., 2000). Elec-
tron microscopy has revealed the presence of adrenergic boutons
forming synaptic specializationswithCRHneurons (Liposits et al.,
1986) and dual in situ hybridization has demonstrated that the
α1b-adrenoceptor is expressed by nearly all the CRH neurons of
the PVN (Day et al., 1999). However, we have found no evidence,
and there have been no electrophysiological reports, of nore-
pinephrine directly activating an inward current or depolarization
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in parvocellular neuroendocrine cells. As noradrenergic recep-
tors are metabotropic, noradrenergic receptors on CRH cells may
initiate signal transduction pathways without altering membrane
conductance. On the other hand, postsynaptic noradrenergic
receptors may stimulate the synthesis of a retrograde messenger
that could trigger the activation of upstream local glutamatergic
circuits. We have preliminary evidence for just such a retrograde
mechanism, inwhich amessenger is released fromCRHneurons in
the PVN and stimulates a spike-dependent increase in glutamater-
gic inputs to the CRH neurons (Jiang and Tasker, unpublished
observation; Figure 2).
In addition to regulating glutamate release, norepinephrine
modulates GABA release onto parvocellular neurons in the PVN
(Figure 2). An electrophysiological study found that about 58% of
putative parvocellular neurons responded to norepinephrine with
an increase in the frequency of spontaneous inhibitory postsynap-
tic currents (IPSCs) that was mediated by α1-adrenoceptors and
was spike-dependent, suggestive of a locus of action upstream
of the GABAergic axon (Han et al., 2002). In another 33% of
the neurons tested, norepinephrine reduced the IPSC frequency,
and this reduction was mediated by α2-adrenoceptors and was
spike-independent, suggesting a presynaptic terminal locus of
action (Han et al., 2002). In another study that speciﬁcally tar-
geted parvocellular neuroendocrine cells with electrophysiological
markers and retrograde staining from themedian eminence, nore-
pinephrine suppressed GABAergic input in 46% of the cells tested,
and this was increased to 100% following blockade of either α1-
adrenoceptors or spike generation (Yang et al., 2008). Consistent
with α2-adrenoceptors located on GABAergic boutons inhibiting
GABA release onto CRH cells, binding assays have reported sub-
stantial binding of radiolabeled clonidine, an α2-adrenoceptor
agonist, in the CRH cell region of the medial parvocellular
PVN (Cummings and Seybold, 1988). Moreover, electrophys-
iological analyses indicate that the α2-adrenoceptor-mediated
decrease in GABA input is reﬂective of a reduced probability
of GABA release (Yang et al., 2008). In keeping with its sup-
pressive effect on neurotransmitter release, the α2-adrenoceptor
is commonly found to suppress norepinephrine release as an
autoreceptor (Raiteri et al., 1992). In support of a stimula-
tory effect of the α2-adrenoceptor on the HPA axis, clonidine
has been reported to enhance CRH secretion from organ-
otypic hypothalamic cultures (Calogero et al., 1988), and intrac-
erebroventricular (Szafarczyk et al., 1990) and intraperitoneal
(Shimizu, 1984) injections of clonidine in vivo induce a surge in
ACTH release.
PLASTICITY OF NOREPINEPHRINE INPUTS
Soon after the discovery that norepinephrine regulates HPA activ-
ity, it was found that ascending noradrenergic signaling plays a
role in the glucocorticoid-induced suppression of the HPA axis,
since depletion of noradrenergic inputs via knife cuts to the
medulla attenuated the increases in hypothalamic CRH expres-
sion and CRH release caused by adrenalectomy (Sawchenko,
1988). Adrenalectomy was also found to reduce binding of radi-
olabeled clonidine in the CRH-expressing region of the medial
parvocellular PVN (Cummings and Seybold, 1988), while α1B-
adrenoceptor expression in the PVN was upregulated following
adrenalectomy (Day et al., 1999). Microdialysis analyses revealed
that adrenalectomy increases the synthesis, release, and turnover
of norepinephrine in the PVN (Pacak et al., 1993), whereas 1 week
of hypercortisolemia, induced by administration of exogenous
glucocorticoid, reduced the synthesis, release, and turnover of
norepinephrine in the PVN (Pacak et al., 1995). This last ﬁnding
is surprising inasmuch as 1 week of chronic variable stress has
been found to increase both the density of noradrenergic synaptic
boutons in the PVN and the number of noradrenergic boutons
abutting CRH-immunoreactive somata and dendrites (Flak et al.,
2009). Additionally, 1 week of repeated intermittent cold stress was
reported to enhance HPA responsivity to an acute immobilization
stress via an increase in α1-adrenoceptor signaling within the PVN
(Ma and Morilak, 2005).
In addition to the effects of adrenalectomy on norepinephrine
release and adrenoceptor expression in the PVN, electrophysiolog-
ical recordings revealed that adrenalectomy results in an increased
fraction of putative parvocellular neuroendocrine cells that are
excited by norepinephrine and a decreased fraction inhibited by
norepinephrine (Yang et al., 2007). Additionally, it was found that
the fraction of cells in which norepinephrine reduced GABA input
was doubled following adrenalectomy, whereas there was an 80%
decrease in the fraction of cells in which norepinephrine enhanced
GABA input (Yang et al., 2008).
Although norepinephrine is thought to be generally excitatory
with regard to CRH release, there is a body of evidence that sug-
gests that norepinephrine suppresses CRH neuron activity in the
absence of glucocorticoids; thus noradrenergic regulation of CRH
cells may be more complex than previously thought. While nore-
pinephrine normally enhances CRH secretion from organotypic
hypothalamic cultures, it was found to reduce basal secretion of
CRH from cultures maintained in a glucocorticoid-free medium
(Szafarczyk et al., 1995). Also, while the α2-adrenoceptor agonist
clonidine normally promotes CRH cell activity (Calogero et al.,
1988), it was found to reduce basal CRH release from organ-
otypic hypothalamic cultures maintained in a glucocorticoid-free
medium (Feuvrier et al., 1998). If noradrenergic signaling from
the brainstem does in fact play a more prominent role in driv-
ing HPA responses to systemic stress than to psychological stress,
adrenalectomized rats might be expected to respond differently to
certain stressors than do intact rats.
PERSPECTIVES AND OUTLOOK
Plasticity of the neural circuitry regulating the HPA axis may
constitute an etiological link between stress exposure and the
subsequent development of HPA dysregulation and associated
pathologies. Research into dysregulation of the HPA axis has
focused mainly on hypersecretion of glucocorticoids, which is
a condition that has been associated with depressive illness.
Autopsies of depressed patients have reported higher than nor-
mal levels of CRH and VP mRNA in the PVN (Raadsheer et al.,
1994, 1995), which is suggestive of elevated pre-mortem CRH
cell activity. It is believed that diminished glucocorticoid-induced
suppression of the HPA axis is an underlying factor in the HPA
hyperactivity found in depressive illness (Gillespie and Nemeroff,
2005). Consistent with this, depressed patients exhibit an atten-
uated suppression of glucocorticoid secretion when given the
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dexamethasone suppression test (i.e., the suppression of HPA
activity by dexamethasone administration; Juruena et al., 2006).
It has been suggested that this glucocorticoid resistance could
result from a reduced expression of the glucocorticoid receptor
(GR; Modell et al., 1997; Boyle et al., 2005), an idea supported by
reports of reduced GR expression in post-mortem brain tissue of
depressed patients (Webster et al., 2002). A similar downregula-
tion of GR is seen in the rat brain following chronic stress (Kitraki
et al., 1999). It is possible that a stress-induced downregulation of
GR serves as a protectivemechanism to limit allostatic load during
periods of elevated glucocorticoid levels. Indeed, there is evidence
that GRmediates the hippocampal deterioration that results from
prolonged glucocorticoid exposure (Packan and Sapolsky, 1990).
Stress could then result in hypercortisolemia by downregulating
GR expression, thereby diminishing glucocorticoid-induced feed-
back inhibition of the HPA axis. However, we propose that a
modiﬁed central drive underlies, at least in part, the link between
exposure to stress and the subsequent development of HPA abnor-
malities. To be clear, we refer to the central drive as it pertains to
the neural circuitry, namely the glutamatergic, GABAergic and
noradrenergic circuitry that regulates the CRH neuronal activity.
There is evidence that enhanced central drive of the HPA axis
contributes to the hypercortisolemia associated with depressive
illness. Speciﬁcally, dexamethasone-resistant depressed patients
exhibit an enhanced ACTH response to metyrapone, a glucocor-
ticoid synthesis inhibitor (Fava et al., 1984; Ur et al., 1992). This
observation is consistent with a hyperactive drive of the HPA axis
that is, in fact, suppressed by glucocorticoids. This glucocorticoid-
independent overdrive of the HPA axis may reﬂect neural circuitry
that favors CRH cell hyperactivity. Interestingly, an enhanced
ACTH response to metyrapone in depressed patients has been
correlated with a reduced efﬁcacy of the selective serotonin re-
uptake inhibitor ﬂuoxetine for the relief of depressive symptoms
(Young et al., 2004), which suggests that resetting to a normal level
of central drive to the CRH neurons may prove an effective ther-
apy in cases of depression that are resistant to serotonin-based
antidepressants.
Stress- and glucocorticoid-induced plasticity of neural cir-
cuitry regulating the HPA axis may constitute a means through
which exposure to stress could play a role in a spectrum of
HPA abnormalities, including aberrant HPA circadian rhythms,
abnormalities in HPA responsivity to stress, and basal HPA dys-
regulation.We hypothesize that this synaptic plasticity constitutes
an etiological link between exposure to stress and a range of affec-
tive and stress-related disorders. We frame this hypothesis on the
basis of three premises: (1) exposure to stress increases the likeli-
hood of developing subsequent HPA dysregulation and associated
pathologies, (2) rodent models have demonstrated that the synap-
tic mechanisms that regulate the HPA axis are highly plastic, and
that synaptic plasticity is induced by both glucocorticoids and
stress, and (3) stress exposure and associated pathologies have,
at times, been linked to hypoactivity of the HPA axis, and this
phenomenon cannot be explained by diminished glucocorticoid-
induced suppression of the HPA axis. With regard to this last
premise, ﬁbromyalgia (Tanriverdi et al., 2007) and chronic fatigue
syndrome (Van Houdenhove et al., 2009) have both been linked to
HPA hypoactivity, and stressful life events have been implicated
in the onset of each of these disorders (Hatcher and House,
2003; Gupta and Silman, 2004). There is also evidence that HPA
hypoactivity is involved in some cases of post-traumatic stress dis-
order (PTSD; Yehuda, 2006) and depression (Morphy et al., 1985;
Penninx et al., 2007; Ahrens et al., 2008). Sexually abused girls
(ages 5–7 years) have exhibited reduced salivary glucocorticoid
levels within months following an abusive incident (King et al.,
2001). Moreover, adult women who were victims of childhood
sexual abuse have exhibited enhanced suppression of glucocor-
ticoid release in response to the dexamethasone suppression test
(Stein et al., 1997). Lastly, in rats, stress can result in HPA hypoac-
tivity under certain circumstances. One study using female rats
found that exposure to intense footshock, followed by 3 weekly
reminders of the stimulus, resulted in lower glucocorticoid lev-
els than those recorded previous to the footshock (Louvart et al.,
2005). Reminders of the footshock involved placing the rat in
a compartment adjacent to the compartment where the foot-
shock had previously occurred, in what was intended as a rodent
model of PTSD.Another study found that rats subjected to chronic
variable stress, followed by several days recovery from the stress,
exhibit attenuated pituitary–adrenal responses to acute novel envi-
ronment and restraint stresses (Ostrander et al., 2006). It should
be noted that there are some mechanisms through which glu-
cocorticoids could actually enhance HPA activity. For example,
glucocorticoids seem to attenuate GABAergic restraint on CRH
cells, as described above; thus, in certain cell types, downregulated
GR expression in response to stress could promote subsequent
HPA hypoactivity. However, there is evidence that stress can, at
times, result in upregulatedGR.GRnumberwas found to be larger
in lymphocytes of combat veterans than in those of non-veterans
(Yehuda et al., 1995). Also, increasedGR binding capacity has been
reported in the rat hippocampus following repeated inescapable
footshock stress (van Dijken et al., 1993). Moreover, the enhanced
response to the dexamethasone suppression test in adult victims
of childhood sexual abuse (Stein et al., 1997) is suggestive of an
increased sensitivity to glucocorticoids, at least at the anterior
pituitary (Cole et al., 2000). Upregulated GR expression could be
a protective response to hypocortisolemia, as some degree of GR
activity may be critical for survival (Cole et al., 1995), and the
initial hypocortisolemia could result from stress-induced synap-
tic plasticity that promotes CRH cell suppression. Indeed, GR
expression generally increases following adrenalectomy (Olpe and
McEwen, 1976; Svec et al., 1989; Isenovic et al., 2006).
With respect to future investigations of neural regulation of the
HPA axis, recent advances in circuit tracing technology have seen
the development of a Cre-dependent retrogradely transported
marker derived from the rabies virus that will allow investiga-
tors to trace the precise sources of innervation to CRH cells (Wall
et al., 2010). This tool will inevitably improve our understanding
of how the brain integrates pertinent information into an HPA
response. Also, one investigative team recently reported that peri-
natal stress, caused by an active construction site adjacent to the
rodent vivarium, resulted in hypercortisolemia that persisted even
after the construction had ended (O’Regan et al., 2010), which
underscores the sensitivity of HPA regulatorymechanisms to envi-
ronmental inﬂuences (at least perinatally), but also serves as a
warning to investigators of the importance of documenting the
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living conditions under which their subjects are kept. Lastly, it
is important that assays of morphological plasticity and changes
in ionotropic receptor expression are accompanied by electro-
physiological recordings, as electrophysiology provides invaluable
information regarding functionalmanifestations of synaptic activ-
ity. Dysregulation of the HPA axis may be a causal factor in a range
of affective and physiological disorders, and there is increasing
evidence that stress can result in persistent changes in HPA reg-
ulation. Rodent models of the past several years have provided
signiﬁcant insight into the etiology of stress-induced aberrations
inHPA activity, but our understanding is still in its infancy. Studies
of synaptic transmission will remain invaluable to this provocative
and promising line of research, as we uncover future targets for
pharmacological intervention.
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